FI49413C - Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi. - Google Patents

Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi.

Info

Publication number
FI49413C
FI49413C FI700883A FI88370A FI49413C FI 49413 C FI49413 C FI 49413C FI 700883 A FI700883 A FI 700883A FI 88370 A FI88370 A FI 88370A FI 49413 C FI49413 C FI 49413C
Authority
FI
Finland
Prior art keywords
preparation
therapeutically active
phenothiazine derivatives
new therapeutically
new
Prior art date
Application number
FI700883A
Other languages
English (en)
Swedish (sv)
Other versions
FI49413B (fi
Inventor
Shirish Chandubhai Amin
David Henry Jones
Donald Robert Maxwell
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI49413B publication Critical patent/FI49413B/fi
Application granted granted Critical
Publication of FI49413C publication Critical patent/FI49413C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI700883A 1969-03-27 1970-03-26 Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi. FI49413C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1621969 1969-03-27

Publications (2)

Publication Number Publication Date
FI49413B FI49413B (fi) 1975-02-28
FI49413C true FI49413C (fi) 1975-06-10

Family

ID=10073337

Family Applications (1)

Application Number Title Priority Date Filing Date
FI700883A FI49413C (fi) 1969-03-27 1970-03-26 Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi.

Country Status (18)

Country Link
US (1) US3709879A (fi)
JP (1) JPS502513B1 (fi)
AT (4) AT299221B (fi)
BE (1) BE748030A (fi)
BR (1) BR7017756D0 (fi)
CA (1) CA931570A (fi)
CH (1) CH516584A (fi)
DK (1) DK125137B (fi)
ES (1) ES377945A1 (fi)
FI (1) FI49413C (fi)
FR (1) FR2035933B1 (fi)
GB (1) GB1258005A (fi)
HU (1) HU162826B (fi)
IE (1) IE34062B1 (fi)
IL (1) IL34170A (fi)
NL (1) NL7004451A (fi)
NO (1) NO126693B (fi)
SE (1) SE363505B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157118A (en) * 1986-09-16 1992-10-20 The Lubrizol Corporation N-substituted thio alkyl phenothiazines
US4785095A (en) * 1986-09-16 1988-11-15 The Lubrizol Corporation N-substituted thio alkyl phenothiazines
US5034019A (en) * 1988-06-23 1991-07-23 The Lubrizol Corporation N-substituted thio alkyl phenothiazines
US5178784A (en) * 1986-09-16 1993-01-12 The Lubrizol Corporation N-substituted thio alkyl phenothiazines
US6333322B1 (en) 1996-03-13 2001-12-25 Eisai Co., Ltd. Nitrogen-containing tricyclic compounds and drugs containing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330826A (en) * 1967-07-11 Process for the production of deriva- tives of phenothiazine and new de- rivatives

Also Published As

Publication number Publication date
CH516584A (fr) 1971-12-15
FR2035933A1 (fi) 1970-12-24
NO126693B (fi) 1973-03-12
JPS502513B1 (fi) 1975-01-27
IL34170A0 (en) 1970-05-21
AT299229B (de) 1972-06-12
FR2035933B1 (fi) 1974-05-24
IE34062B1 (en) 1975-01-22
SE363505B (fi) 1974-01-21
BE748030A (fr) 1970-09-28
BR7017756D0 (pt) 1973-02-13
FI49413B (fi) 1975-02-28
DE2014860A1 (de) 1970-10-08
IE34062L (en) 1970-09-27
ES377945A1 (es) 1972-10-16
AT299227B (de) 1972-06-12
CA931570A (en) 1973-08-07
HU162826B (fi) 1973-04-28
GB1258005A (fi) 1971-12-22
NL7004451A (fi) 1970-09-29
US3709879A (en) 1973-01-09
IL34170A (en) 1973-10-25
DK125137B (da) 1973-01-02
AT299221B (de) 1972-06-12
AT299228B (de) 1972-06-12
DE2014860B2 (de) 1977-03-24

Similar Documents

Publication Publication Date Title
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI49300C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI49958C (fi) Menetelmä terapeuttisesti aktiivisen aminoguanidiini-johdannaisen valm istamiseksi.
FI52335C (fi) Menetelmä terapeuttisesti vaikuttavien trisyklisten etyyliamiini-johda nnaisten valmistamiseksi.
FI46373C (fi) Menetelmä fenyyliaminopropaanin uusien terapeuttisesti käyttökelpoiste n johdannaisten valmistamiseksi.
FI52715C (fi) Menetelmä terapeuttisesti käytettävien vitamiini A-happoamidien valmis tamiseksi.
FI48728C (fi) Analogiamenetelmä terapeuttisesti käytettävien fenyylietikkahappojohda nnaisten valmistamiseksi.
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
FI49504C (fi) Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI51342C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien hydroksifenyylialkyylia miinijohdannaisten valmistamiseksi.
FI49413C (fi) Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI50420C (fi) Menetelmä terapeuttisesti aktiivisten 4-pyrimidinyyli-1,4-dihydropyrid iinijohdannaisten valmistamiseksi
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI52577C (fi) Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI52082C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,4-bentsodiatsepin-2-on ien valmistamiseksi
NO740982L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive omega-nitroacetofenonderivater.
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.
FI50243C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 3-hydroksi-9- atsamorfinaanien valmistamiseksi.
FI47661C (fi) Menetelmä terapeuttisesti vaikuttavien bentsofuraanijohdannaisten valm istamiseksi.
FI45555C (fi) Menetelmä terapeuttisesti käytettävien strofantidiinityyppisten sydäng lykosidijohdannaisten valmistamiseksi.